1. Sirohi B, Powles R . Multiple myeloma. Lancet 2004; 363: 875–887.
2. Zipori D, Duksin D, Tamir M, Argaman A, Toledo J, Malik Z . Cultured mouse marrow stromal cell lines. II. Distinct subtypes differing in morphology, collagen types, myelopoietic factors, and leukemic cell growth modulating activities. J Cell Physiol 1985; 122: 81–90.
3. Belaid Z, Hubint F, Humblet C, Boniver J, Nusgens B, Defresne MP . Differential expression of vascular endothelial growth factor and its receptors in hematopoietic and fatty bone marrow: evidence that neuropilin-1 is produced by fat cells. Haematologica 2005; 90: 400–401.
4. Vanderkerken K, Asosingh K, Willems A, De Raeve H, Couck P, Gorus F et al. The 5T2MM murine model of multiple myeloma: maintenance and analysis. Methods Mol Med 2005; 113: 191–205.
5. Kumar S, Greipp PR, Haug J, Kline M, Chng WJ, Blood E et al. Gene expression profiling of myeloma cells at diagnosis can predict response to therapy with thalidomide and dexamethasone combination. ASH Annual Meeting Abstracts 2005; 106: 508.